Experimental cell therapy trial opens for advanced cancer patients
NCT ID NCT07482319
Summary
This early-stage study is testing a new cell therapy called GK01 in patients with advanced solid tumors who have run out of standard treatment options. Researchers will give 15 participants injections of their own modified immune cells to see if the treatment is safe and what dose they can tolerate. The main goal is to find the highest safe dose and understand side effects, while also checking if the therapy shows any signs of helping control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.